Weekly Recap | WuXi Biologics -0.93%, highs then a fadeWeekly Review·Oct 10, 2026 at 08:14 AMWXXWY-2.32%
Weekly Recap | Upstream Bio -6.75%, consensus target above spotWeekly Review·Oct 10, 2026 at 08:03 AMUPB-5.11%
Weekly Recap | Tango Therapeutics +2.45%, most brokers rate it buyWeekly Review·Oct 10, 2026 at 07:54 AMTNGX-0.59%
Weekly Recap | Prime Medicine +33.89%, most brokers rate it buyWeekly Review·Oct 10, 2026 at 07:24 AMPRME-5.26%
Weekly Recap | Oncolytics Biotech -11.73%, hitting a one-month lowWeekly Review·Oct 10, 2026 at 07:22 AMONCY-8.53%
Weekly Recap | Beigene -1.01%, most brokers rate it buyWeekly Review·Oct 10, 2026 at 07:17 AMONC-0.98%
Weekly Recap | Legend Biotech +0.27%, most brokers rate it buyWeekly Review·Oct 10, 2026 at 06:58 AMLEGN-2.36%
Cancer cell therapy company Arcellx opened up 78%, marking the largest intraday gain for a U.S. IPO, and Gilead Sciences will acquire the company at a price of $115 per shareWallstreetcn·Feb 23, 2026 at 02:35 PMFBT-0.35%IBBQ-0.55%
Global news you need to know before Monday's U.S. stock market opensWallstreetcn·Feb 23, 2026 at 01:57 PMACLX0.00%.SPX-0.07%
